Zenas BioPharma, Inc.
- ZBIO
- NASDAQ
- Biotechnology
- Immunology Biotech
- Antibody Therapeutics
- Clinical-Stage Biopharma
$24.84
Today −2.20%Quote Oct 16, 2026, 08:00 PM UTC
−22.30%over the last month
Max drawdown −24.8%From 1-month high −24.8%3 months −19.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$1.62B
Quote Oct 16
Next earnings
Nov 18
Expected, not confirmed
Analyst target
$43.50
+75.1% from here
Floor
$23.73
4.5% below price
Where the price sits
5 analysts
Analyst range, low to high
$32.00$55.00
- Price $24.84
- Resistance $25.49
- Consensus $43.50
The price is right under resistance. Analysts' average target sits about 75% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ZBIOPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
167